Patent Number: 6,166,079

Title: DFMO for the treatment or prevention of cervical intraepithelial neoplasia

Abstract: Methods for treating, preventing, controlling the growth of and/or reducing the risk of developing cervical cancer, particularly in patients with cervical intraepithelial neoplasia are provided employing pharmaceutically acceptable preparations of DFMO. Methods for treating a patient having cervical intraepithelial neoplasia, which methods comprise administering DFMO alone or in combination with a cytotoxic or cytostatic agent, are also provided.

Inventors: Follen; Michele (Houston, TX), Hong; Wuan K. (Houston, TX), Lotan; Reuben (Kingwood, TX), Hittelman; Walter (Houston, TX), Nishioka; Kenji (Houston, TX)

Assignee: Board of Regents, The University of Texas System

International Classification: A61K 31/198 (20060101); A61K 31/185 (20060101); A61K 31/195 (20060101); A61K 031/195 ()

Expiration Date: 12/26/2017